Asset Details
Do you wish to reserve the book?
Risk of Cancer in Inflammatory Bowel Disease and Pitfalls in Oncologic Therapy
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Risk of Cancer in Inflammatory Bowel Disease and Pitfalls in Oncologic Therapy
Do you wish to request the book?
Risk of Cancer in Inflammatory Bowel Disease and Pitfalls in Oncologic Therapy
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Risk of Cancer in Inflammatory Bowel Disease and Pitfalls in Oncologic Therapy
2023
Overview
Background
Inflammatory bowel disease (IBD), represented by ulcerative colitis and Crohn’s disease, is an idiopathic condition caused by a dysregulated immune response to host intestinal microflora, leading to chronic relapsing intestinal inflammation. Individuals with IBD are more prone to die from several diseases, including cancer.
Methods
An extensive search was conducted of PubMed using the following medical subject heading-“inflammatory bowel disease” OR “Crohn’s disease” OR “ulcerative colitis” AND “cancer.”
Results
In this review article, we discuss the oncogenic mechanisms and genomics of colitis-associated colorectal cancer. Beyond this, we describe the multiple other malignancies that IBD patients are at risk for, discuss caveats in the screening and diagnosis of those cancers, and shed light on pitfalls on the management and treatment of cancer in IBD patients.
Conclusion
Patients, caregivers, and health professionals who deal with IBD must be educated on how to identify warning signs so that cancers can be diagnosed and treated as early as possible.
Publisher
Springer US,Springer Nature B.V
Subject
